Page last updated: 2024-09-03

gefitinib and sumatriptan

gefitinib has been researched along with sumatriptan in 5 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(sumatriptan)
Trials
(sumatriptan)
Recent Studies (post-2010) (sumatriptan)
5,2315662,9192,405461480

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)sumatriptan (IC50)
5-hydroxytryptamine receptor 3EHomo sapiens (human)0.0073
5-hydroxytryptamine receptor 3BHomo sapiens (human)0.0073
5-hydroxytryptamine receptor 1AHomo sapiens (human)0.4497
Carboxypeptidase MHomo sapiens (human)0.02
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.64
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.722
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.64
5-hydroxytryptamine receptor 1DHomo sapiens (human)0.3091
5-hydroxytryptamine receptor 1BHomo sapiens (human)0.0131
5-hydroxytryptamine receptor 2AHomo sapiens (human)7.9433
5-hydroxytryptamine receptor 2CHomo sapiens (human)3.9753
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.804
5-hydroxytryptamine receptor 1DRattus norvegicus (Norway rat)0.061
5-hydroxytryptamine receptor 1EHomo sapiens (human)5.5
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.64
5-hydroxytryptamine receptor 3AHomo sapiens (human)0.0078
5-hydroxytryptamine receptor 5AHomo sapiens (human)0.5012
5-hydroxytryptamine receptor 1DSus scrofa (pig)0.02
5-hydroxytryptamine receptor 1AMus musculus (house mouse)0.45
5-hydroxytryptamine receptor 3DHomo sapiens (human)0.0073
5-hydroxytryptamine receptor 3CHomo sapiens (human)0.0073
Multidrug and toxin extrusion protein 1Homo sapiens (human)6.7

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Ekins, S; Williams, AJ; Xu, JJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for gefitinib and sumatriptan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

4 other study(ies) available for gefitinib and sumatriptan

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013